Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185666 · ClinicalTrials.gov registry record · Phase 1
Cyberknife Precision Radiation Delivery System for Tumors of the Spine
A Phase 1 study of Spinal Cord Cancer and Brain (Nervous System) Cancers, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00185666: Completed Phase 1 study of Spinal Cord Cancer and Brain (Nervous System) Cancers, sponsored by Stanford University.
NCT00185666 is a Phase 1 study of Spinal Cord Cancer and Brain (Nervous System) Cancers that has completed, run by Stanford University. The registered enrollment target is 200 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185666, a Phase 1 study of Spinal Cord Cancer and Brain (Nervous System) Cancers, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.
Conditions Studied
Interventions
- PROCEDURE Stereotactic radiosurgery
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2002-05 |
| Est. Completion | 2006-05 |
| Phase | Phase 1 |
What the finished NCT00185666 record still lists
NCT00185666 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (233% higher).
The record links to 2 conditions, with Spinal Cord Cancer appearing as the primary indexed condition, and to 1 intervention - of which Stereotactic radiosurgery is the first listed.
NCT00185666 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00185666 about?
NCT00185666 is a clinical study titled "Cyberknife Precision Radiation Delivery System for Tumors of the Spine". The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.
What is the current status of trial NCT00185666?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 200 participants. The study started on 2002-05. Estimated completion is 2006-05.
What conditions does trial NCT00185666 study?
This clinical trial studies the following conditions: Spinal Cord Cancer, Brain (Nervous System) Cancers.
What interventions are being tested in trial NCT00185666?
The interventions under investigation include: Stereotactic radiosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00185666?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00185666 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00185666's enrollment target sits among peer trials
200 259th of 2000 higher than 1,724 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia